197 related articles for article (PubMed ID: 19932217)
1. Hepatitis B vaccination strategies tailored to different endemicity levels: some considerations.
Rots NY; Wijmenga-Monsuur AJ; Luytjes W; Kaaijk P; de Graaf TW; van der Zeijst BA; Boog CJ
Vaccine; 2010 Jan; 28(4):893-900. PubMed ID: 19932217
[TBL] [Abstract][Full Text] [Related]
2. Model based analysis of hepatitis B vaccination strategies in the Netherlands.
Kretzschmar M; Mangen MJ; van de Laar M; de Wit A
Vaccine; 2009 Feb; 27(8):1254-60. PubMed ID: 19118594
[TBL] [Abstract][Full Text] [Related]
3. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
[TBL] [Abstract][Full Text] [Related]
4. Benefits of early hepatitis B immunization programs for newborns and infants.
Van Herck K; Van Damme P
Pediatr Infect Dis J; 2008 Oct; 27(10):861-9. PubMed ID: 18776823
[TBL] [Abstract][Full Text] [Related]
5. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M
Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
[TBL] [Abstract][Full Text] [Related]
6. [Prevention of hepatitis A and hepatitis B by vaccination].
Buisson Y; Meyran M
Ann Gastroenterol Hepatol (Paris); 1995 Oct; 31(5):306-8; discussion 308-9. PubMed ID: 8572566
[TBL] [Abstract][Full Text] [Related]
7. The underestimated risk of hepatitis A and hepatitis B: benefits of an accelerated vaccination schedule.
Keystone JS; Hershey JH
Int J Infect Dis; 2008 Jan; 12(1):3-11. PubMed ID: 17643334
[TBL] [Abstract][Full Text] [Related]
8. Control of hepatocellular carcinoma through hepatitis B vaccination in areas of high endemicity: perspectives for global liver cancer prevention.
Plymoth A; Viviani S; Hainaut P
Cancer Lett; 2009 Dec; 286(1):15-21. PubMed ID: 19836128
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B immunization in adolescents.
Lawrence MH; Goldstein MA
J Adolesc Health; 1995 Oct; 17(4):234-43. PubMed ID: 8580124
[TBL] [Abstract][Full Text] [Related]
10. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
Hung HF; Chen TH
Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
[TBL] [Abstract][Full Text] [Related]
11. [Prevention of hepatitis A and hepatitis B with vaccination].
Buisson Y; Meyran M
Bull Acad Natl Med; 1995 Feb; 179(2):367-74; discussion 373-5. PubMed ID: 7614064
[TBL] [Abstract][Full Text] [Related]
12. The changing face of the epidemiology of type A, B, and D viral hepatitis in Italy, following the implementation of vaccination.
Romanò L; Paladini S; Tagliacarne C; Zappa A; Zanetti AR
Vaccine; 2009 May; 27(25-26):3439-42. PubMed ID: 19200848
[TBL] [Abstract][Full Text] [Related]
13. Risk of hepatitis B for travelers: is vaccination for all travelers really necessary?
Sonder GJ; van Rijckevorsel GG; van den Hoek A
J Travel Med; 2009; 16(1):18-22. PubMed ID: 19192123
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B vaccination in a hyper-endemic tribal community from India: assessment after three years.
Murhekar MV; Murhekar KM; Sehgal SC
Vaccine; 2004 Dec; 23(3):399-403. PubMed ID: 15530686
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B surface antibody response of household contacts of hepatitis B virus carriers in Palestine.
Adwan K; Abu-Hasan N; Adwan G; Abu-Khater K
East Mediterr Health J; 2005 May; 11(3):494-8. PubMed ID: 16602472
[TBL] [Abstract][Full Text] [Related]
16. [Seroepidemiological study and program of vaccination against hepatitis B in school children in Extremadura].
Gimeno Ortiz A; Jiménez Romano R; Zarallo Barbosa T
Rev Sanid Hig Publica (Madr); 1993; 67(5):369-76. PubMed ID: 7732304
[TBL] [Abstract][Full Text] [Related]
17. [Protection of children born to hepatitis-B-infected mothers].
Boot HJ; Vermeer-de Bondt PE; Kimman TG
Ned Tijdschr Geneeskd; 2004 Sep; 148(37):1816-8. PubMed ID: 15495509
[TBL] [Abstract][Full Text] [Related]
18. [Control of hepatitis B in French Polynesia with a program of systematic vaccination of newborns with the Genhevac B vaccine].
Moulia-Pelat JP; Spiegel A; Excler JL; Martin P; Roux JF; Boutin JP; Blondeau C; Saliou P
Sante; 1996; 6(1):11-5. PubMed ID: 8612008
[TBL] [Abstract][Full Text] [Related]
19. The global impact of vaccination against hepatitis B: a historical overview.
Zanetti AR; Van Damme P; Shouval D
Vaccine; 2008 Nov; 26(49):6266-73. PubMed ID: 18848855
[TBL] [Abstract][Full Text] [Related]
20. Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme.
Su FH; Chen JD; Cheng SH; Sung KY; Jeng JJ; Chu FY
J Viral Hepat; 2008 Jan; 15(1):14-9. PubMed ID: 18088240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
